Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Hyaluronic Acid for Glenohumeral Osteoarthritis
NCT02984228Phase 4Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Dec 2014
- Primary completion
- Nov 2020
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma in glenohumeral osteoarthritis (2 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Shoulder Pain and Disability Index at 52 weeks. Started Dec 2014; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
glenohumeral osteoarthritis
Beyond the preview
Go deeper on NCT02984228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984228.